Role of Renal Venous Oxygen Pressure for Renal Function Monitoring After Related Living-Donor Kidney Transplantation: Cohort Study

Monitoring of renal function after kidney transplantation (KT) is performed by measuring serum creatinine (SCr), urine volumes (UV), and glomerular filtration rate (GFR). Other methods based on oxygen metabolism, such as the renal venous oxygen pressure (PrvO2), may be useful. The aim of this study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation proceedings 2024-01, Vol.56 (1), p.23-30
Hauptverfasser: Diego, Escarramán Martínez, Fernández Bravo, Monserrat, Kammar Garcia, Ashuin, Guerrero Gutiérrez, Manuel Alberto, Cendejas Rios, Emilio, Escorza Molina, Carla Adelina, Meza Comparan, Héctor David, Mancilla-Galindo, Javier, Noriega Salas, Lorena, Bernaldez Gómez, Germán, Díaz, Jesús Salvador Sánchez
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 30
container_issue 1
container_start_page 23
container_title Transplantation proceedings
container_volume 56
creator Diego, Escarramán Martínez
Fernández Bravo, Monserrat
Kammar Garcia, Ashuin
Guerrero Gutiérrez, Manuel Alberto
Cendejas Rios, Emilio
Escorza Molina, Carla Adelina
Meza Comparan, Héctor David
Mancilla-Galindo, Javier
Noriega Salas, Lorena
Bernaldez Gómez, Germán
Díaz, Jesús Salvador Sánchez
description Monitoring of renal function after kidney transplantation (KT) is performed by measuring serum creatinine (SCr), urine volumes (UV), and glomerular filtration rate (GFR). Other methods based on oxygen metabolism, such as the renal venous oxygen pressure (PrvO2), may be useful. The aim of this study was to explore the correlation between PrvO2 and SCr, UV, and GFR 5 days after KT (SCr5, UV5, and GFR5, respectively). We conducted a prospective cohort study in adults scheduled for living donor KT. A venous blood sample was taken from the renal vein after declamping the renal artery, and blood gas determinations were made. Correlation analyses between PrvO2 and SCr5, UV5, and GFR5 were done by calculating Spearman's correlation coefficient with generalized linear models (GLM). A Spearman's correlation analysis was performed between the percentage decrease in SCr (%ΔSCr) and PrvO2. A GLM was also performed to determine the association of PrvO2 with slow graft function (SGF). The study included 42 patients, of whom 67% were men. The median age was 31 years (IQR, 27-43.5). PrvO2 was negatively correlated with SCr5 (ρ = -0.53, P = .003), and positively correlated with GFR5 (ρ = 0.49, P = .001) and %ΔSCr (ρ = 0.47, P = .002). A higher PrvO2 was associated with an increase in GFR in univariable (β = 1.24, 95% CI, 0.56-1.93, P = .001) and multivariable (β = 1.24, 95% CI, 0.53-1.94, P = .001) analyses. No association was found between PrvO2 and SGF. PrvO2 could be used to monitor renal function in the first 5 days after related living-donor KT, given its good correlation with SCr and GFR.
doi_str_mv 10.1016/j.transproceed.2023.11.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2917555387</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134523007662</els_id><sourcerecordid>2917555387</sourcerecordid><originalsourceid>FETCH-LOGICAL-c323t-b8c61ef582b9ca364b83d81f7d47d069b53350390b63c10982636fad64b3086f3</originalsourceid><addsrcrecordid>eNqNkU9vEzEQxS1ERUPgKyCLE5dd_GfX8fZWpZQiUhWVwtXy2rPF0cZubW9Frv3kdUgqcezJsuf3PDPvIfSRkpoSKj6v6xy1T3cxGABbM8J4TWlNKHmFZlQueMUE46_RjJCGVpQ37TF6m9KalDtr-Bt0zCVrhCTNDD1ehxFwGPA1eD3i3-DDlPDV3-0tePwjQkpTBDyEeADOJ2-yCx5fBu9yiM7f4tMhw64-6gwWr9xDeazOgi-i78562OKbf_OO2me9E5_gZfgTYsY_82S379DRoMcE7w_nHP06_3KzvKhWV1-_LU9XleGM56qXRlAYWsn6zmguml5yK-mwsM3CEtH1Lect4R3pBTeUdJIJLgZtC8iJFAOfo0_7f4tx9xOkrDYuGRjLWFCWVqyji7ZteTFwjk72qIkhpQiDuotuo-NWUaJ2Gai1-j8DtctAUapKBkX84dBn6jel9ix9Nr0AZ3sAyrYPDqJKxoE3YF0Ek5UN7iV9ngBBIKBF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2917555387</pqid></control><display><type>article</type><title>Role of Renal Venous Oxygen Pressure for Renal Function Monitoring After Related Living-Donor Kidney Transplantation: Cohort Study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Diego, Escarramán Martínez ; Fernández Bravo, Monserrat ; Kammar Garcia, Ashuin ; Guerrero Gutiérrez, Manuel Alberto ; Cendejas Rios, Emilio ; Escorza Molina, Carla Adelina ; Meza Comparan, Héctor David ; Mancilla-Galindo, Javier ; Noriega Salas, Lorena ; Bernaldez Gómez, Germán ; Díaz, Jesús Salvador Sánchez</creator><creatorcontrib>Diego, Escarramán Martínez ; Fernández Bravo, Monserrat ; Kammar Garcia, Ashuin ; Guerrero Gutiérrez, Manuel Alberto ; Cendejas Rios, Emilio ; Escorza Molina, Carla Adelina ; Meza Comparan, Héctor David ; Mancilla-Galindo, Javier ; Noriega Salas, Lorena ; Bernaldez Gómez, Germán ; Díaz, Jesús Salvador Sánchez</creatorcontrib><description>Monitoring of renal function after kidney transplantation (KT) is performed by measuring serum creatinine (SCr), urine volumes (UV), and glomerular filtration rate (GFR). Other methods based on oxygen metabolism, such as the renal venous oxygen pressure (PrvO2), may be useful. The aim of this study was to explore the correlation between PrvO2 and SCr, UV, and GFR 5 days after KT (SCr5, UV5, and GFR5, respectively). We conducted a prospective cohort study in adults scheduled for living donor KT. A venous blood sample was taken from the renal vein after declamping the renal artery, and blood gas determinations were made. Correlation analyses between PrvO2 and SCr5, UV5, and GFR5 were done by calculating Spearman's correlation coefficient with generalized linear models (GLM). A Spearman's correlation analysis was performed between the percentage decrease in SCr (%ΔSCr) and PrvO2. A GLM was also performed to determine the association of PrvO2 with slow graft function (SGF). The study included 42 patients, of whom 67% were men. The median age was 31 years (IQR, 27-43.5). PrvO2 was negatively correlated with SCr5 (ρ = -0.53, P = .003), and positively correlated with GFR5 (ρ = 0.49, P = .001) and %ΔSCr (ρ = 0.47, P = .002). A higher PrvO2 was associated with an increase in GFR in univariable (β = 1.24, 95% CI, 0.56-1.93, P = .001) and multivariable (β = 1.24, 95% CI, 0.53-1.94, P = .001) analyses. No association was found between PrvO2 and SGF. PrvO2 could be used to monitor renal function in the first 5 days after related living-donor KT, given its good correlation with SCr and GFR.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2023.11.010</identifier><identifier>PMID: 38246804</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Cohort Studies ; Creatinine ; Female ; Glomerular Filtration Rate ; Humans ; Kidney ; Kidney Transplantation - adverse effects ; Living Donors ; Male ; Oxygen ; Prospective Studies ; Renal Veins</subject><ispartof>Transplantation proceedings, 2024-01, Vol.56 (1), p.23-30</ispartof><rights>2023 Elsevier Inc.</rights><rights>Copyright © 2023 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c323t-b8c61ef582b9ca364b83d81f7d47d069b53350390b63c10982636fad64b3086f3</cites><orcidid>0000-0003-3190-0258</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041134523007662$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38246804$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diego, Escarramán Martínez</creatorcontrib><creatorcontrib>Fernández Bravo, Monserrat</creatorcontrib><creatorcontrib>Kammar Garcia, Ashuin</creatorcontrib><creatorcontrib>Guerrero Gutiérrez, Manuel Alberto</creatorcontrib><creatorcontrib>Cendejas Rios, Emilio</creatorcontrib><creatorcontrib>Escorza Molina, Carla Adelina</creatorcontrib><creatorcontrib>Meza Comparan, Héctor David</creatorcontrib><creatorcontrib>Mancilla-Galindo, Javier</creatorcontrib><creatorcontrib>Noriega Salas, Lorena</creatorcontrib><creatorcontrib>Bernaldez Gómez, Germán</creatorcontrib><creatorcontrib>Díaz, Jesús Salvador Sánchez</creatorcontrib><title>Role of Renal Venous Oxygen Pressure for Renal Function Monitoring After Related Living-Donor Kidney Transplantation: Cohort Study</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Monitoring of renal function after kidney transplantation (KT) is performed by measuring serum creatinine (SCr), urine volumes (UV), and glomerular filtration rate (GFR). Other methods based on oxygen metabolism, such as the renal venous oxygen pressure (PrvO2), may be useful. The aim of this study was to explore the correlation between PrvO2 and SCr, UV, and GFR 5 days after KT (SCr5, UV5, and GFR5, respectively). We conducted a prospective cohort study in adults scheduled for living donor KT. A venous blood sample was taken from the renal vein after declamping the renal artery, and blood gas determinations were made. Correlation analyses between PrvO2 and SCr5, UV5, and GFR5 were done by calculating Spearman's correlation coefficient with generalized linear models (GLM). A Spearman's correlation analysis was performed between the percentage decrease in SCr (%ΔSCr) and PrvO2. A GLM was also performed to determine the association of PrvO2 with slow graft function (SGF). The study included 42 patients, of whom 67% were men. The median age was 31 years (IQR, 27-43.5). PrvO2 was negatively correlated with SCr5 (ρ = -0.53, P = .003), and positively correlated with GFR5 (ρ = 0.49, P = .001) and %ΔSCr (ρ = 0.47, P = .002). A higher PrvO2 was associated with an increase in GFR in univariable (β = 1.24, 95% CI, 0.56-1.93, P = .001) and multivariable (β = 1.24, 95% CI, 0.53-1.94, P = .001) analyses. No association was found between PrvO2 and SGF. PrvO2 could be used to monitor renal function in the first 5 days after related living-donor KT, given its good correlation with SCr and GFR.</description><subject>Adult</subject><subject>Cohort Studies</subject><subject>Creatinine</subject><subject>Female</subject><subject>Glomerular Filtration Rate</subject><subject>Humans</subject><subject>Kidney</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Living Donors</subject><subject>Male</subject><subject>Oxygen</subject><subject>Prospective Studies</subject><subject>Renal Veins</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU9vEzEQxS1ERUPgKyCLE5dd_GfX8fZWpZQiUhWVwtXy2rPF0cZubW9Frv3kdUgqcezJsuf3PDPvIfSRkpoSKj6v6xy1T3cxGABbM8J4TWlNKHmFZlQueMUE46_RjJCGVpQ37TF6m9KalDtr-Bt0zCVrhCTNDD1ehxFwGPA1eD3i3-DDlPDV3-0tePwjQkpTBDyEeADOJ2-yCx5fBu9yiM7f4tMhw64-6gwWr9xDeazOgi-i78562OKbf_OO2me9E5_gZfgTYsY_82S379DRoMcE7w_nHP06_3KzvKhWV1-_LU9XleGM56qXRlAYWsn6zmguml5yK-mwsM3CEtH1Lect4R3pBTeUdJIJLgZtC8iJFAOfo0_7f4tx9xOkrDYuGRjLWFCWVqyji7ZteTFwjk72qIkhpQiDuotuo-NWUaJ2Gai1-j8DtctAUapKBkX84dBn6jel9ix9Nr0AZ3sAyrYPDqJKxoE3YF0Ek5UN7iV9ngBBIKBF</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Diego, Escarramán Martínez</creator><creator>Fernández Bravo, Monserrat</creator><creator>Kammar Garcia, Ashuin</creator><creator>Guerrero Gutiérrez, Manuel Alberto</creator><creator>Cendejas Rios, Emilio</creator><creator>Escorza Molina, Carla Adelina</creator><creator>Meza Comparan, Héctor David</creator><creator>Mancilla-Galindo, Javier</creator><creator>Noriega Salas, Lorena</creator><creator>Bernaldez Gómez, Germán</creator><creator>Díaz, Jesús Salvador Sánchez</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3190-0258</orcidid></search><sort><creationdate>202401</creationdate><title>Role of Renal Venous Oxygen Pressure for Renal Function Monitoring After Related Living-Donor Kidney Transplantation: Cohort Study</title><author>Diego, Escarramán Martínez ; Fernández Bravo, Monserrat ; Kammar Garcia, Ashuin ; Guerrero Gutiérrez, Manuel Alberto ; Cendejas Rios, Emilio ; Escorza Molina, Carla Adelina ; Meza Comparan, Héctor David ; Mancilla-Galindo, Javier ; Noriega Salas, Lorena ; Bernaldez Gómez, Germán ; Díaz, Jesús Salvador Sánchez</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c323t-b8c61ef582b9ca364b83d81f7d47d069b53350390b63c10982636fad64b3086f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Cohort Studies</topic><topic>Creatinine</topic><topic>Female</topic><topic>Glomerular Filtration Rate</topic><topic>Humans</topic><topic>Kidney</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Living Donors</topic><topic>Male</topic><topic>Oxygen</topic><topic>Prospective Studies</topic><topic>Renal Veins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diego, Escarramán Martínez</creatorcontrib><creatorcontrib>Fernández Bravo, Monserrat</creatorcontrib><creatorcontrib>Kammar Garcia, Ashuin</creatorcontrib><creatorcontrib>Guerrero Gutiérrez, Manuel Alberto</creatorcontrib><creatorcontrib>Cendejas Rios, Emilio</creatorcontrib><creatorcontrib>Escorza Molina, Carla Adelina</creatorcontrib><creatorcontrib>Meza Comparan, Héctor David</creatorcontrib><creatorcontrib>Mancilla-Galindo, Javier</creatorcontrib><creatorcontrib>Noriega Salas, Lorena</creatorcontrib><creatorcontrib>Bernaldez Gómez, Germán</creatorcontrib><creatorcontrib>Díaz, Jesús Salvador Sánchez</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diego, Escarramán Martínez</au><au>Fernández Bravo, Monserrat</au><au>Kammar Garcia, Ashuin</au><au>Guerrero Gutiérrez, Manuel Alberto</au><au>Cendejas Rios, Emilio</au><au>Escorza Molina, Carla Adelina</au><au>Meza Comparan, Héctor David</au><au>Mancilla-Galindo, Javier</au><au>Noriega Salas, Lorena</au><au>Bernaldez Gómez, Germán</au><au>Díaz, Jesús Salvador Sánchez</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Renal Venous Oxygen Pressure for Renal Function Monitoring After Related Living-Donor Kidney Transplantation: Cohort Study</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2024-01</date><risdate>2024</risdate><volume>56</volume><issue>1</issue><spage>23</spage><epage>30</epage><pages>23-30</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><abstract>Monitoring of renal function after kidney transplantation (KT) is performed by measuring serum creatinine (SCr), urine volumes (UV), and glomerular filtration rate (GFR). Other methods based on oxygen metabolism, such as the renal venous oxygen pressure (PrvO2), may be useful. The aim of this study was to explore the correlation between PrvO2 and SCr, UV, and GFR 5 days after KT (SCr5, UV5, and GFR5, respectively). We conducted a prospective cohort study in adults scheduled for living donor KT. A venous blood sample was taken from the renal vein after declamping the renal artery, and blood gas determinations were made. Correlation analyses between PrvO2 and SCr5, UV5, and GFR5 were done by calculating Spearman's correlation coefficient with generalized linear models (GLM). A Spearman's correlation analysis was performed between the percentage decrease in SCr (%ΔSCr) and PrvO2. A GLM was also performed to determine the association of PrvO2 with slow graft function (SGF). The study included 42 patients, of whom 67% were men. The median age was 31 years (IQR, 27-43.5). PrvO2 was negatively correlated with SCr5 (ρ = -0.53, P = .003), and positively correlated with GFR5 (ρ = 0.49, P = .001) and %ΔSCr (ρ = 0.47, P = .002). A higher PrvO2 was associated with an increase in GFR in univariable (β = 1.24, 95% CI, 0.56-1.93, P = .001) and multivariable (β = 1.24, 95% CI, 0.53-1.94, P = .001) analyses. No association was found between PrvO2 and SGF. PrvO2 could be used to monitor renal function in the first 5 days after related living-donor KT, given its good correlation with SCr and GFR.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38246804</pmid><doi>10.1016/j.transproceed.2023.11.010</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3190-0258</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2024-01, Vol.56 (1), p.23-30
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_2917555387
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Cohort Studies
Creatinine
Female
Glomerular Filtration Rate
Humans
Kidney
Kidney Transplantation - adverse effects
Living Donors
Male
Oxygen
Prospective Studies
Renal Veins
title Role of Renal Venous Oxygen Pressure for Renal Function Monitoring After Related Living-Donor Kidney Transplantation: Cohort Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T02%3A17%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Renal%20Venous%20Oxygen%20Pressure%20for%20Renal%20Function%20Monitoring%20After%20Related%20Living-Donor%20Kidney%20Transplantation:%20Cohort%20Study&rft.jtitle=Transplantation%20proceedings&rft.au=Diego,%20Escarram%C3%A1n%20Mart%C3%ADnez&rft.date=2024-01&rft.volume=56&rft.issue=1&rft.spage=23&rft.epage=30&rft.pages=23-30&rft.issn=0041-1345&rft.eissn=1873-2623&rft_id=info:doi/10.1016/j.transproceed.2023.11.010&rft_dat=%3Cproquest_cross%3E2917555387%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2917555387&rft_id=info:pmid/38246804&rft_els_id=S0041134523007662&rfr_iscdi=true